These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
694 related articles for article (PubMed ID: 33171483)
1. A compound downregulation of SRRM2 and miR-27a-3p with upregulation of miR-27b-3p in PBMCs of Parkinson's patients is associated with the early stage onset of disease. Fazeli S; Motovali-Bashi M; Peymani M; Hashemi MS; Etemadifar M; Nasr-Esfahani MH; Ghaedi K PLoS One; 2020; 15(11):e0240855. PubMed ID: 33171483 [TBL] [Abstract][Full Text] [Related]
2. Correction: A compound downregulation of SRRM2 and miR-27a-3p with upregulation of miR-27b-3p in PBMCs of Parkinson's patients is associated with the early stage onset of disease. Fazeli S; Motovali-Bashi M; Peymani M; Hashemi MS; Etemadifar M; Hossein Nasr-Esfahani M; Ghaedi K PLoS One; 2020; 15(12):e0244776. PubMed ID: 33378389 [TBL] [Abstract][Full Text] [Related]
3. Modified level of miR-376a is associated with Parkinson's disease. Baghi M; Rostamian Delavar M; Yadegari E; Peymani M; Pozo D; Hossein Nasr-Esfahani M; Ghaedi K J Cell Mol Med; 2020 Feb; 24(4):2622-2634. PubMed ID: 31930701 [TBL] [Abstract][Full Text] [Related]
4. miR-27a and miR-27b regulate autophagic clearance of damaged mitochondria by targeting PTEN-induced putative kinase 1 (PINK1). Kim J; Fiesel FC; Belmonte KC; Hudec R; Wang WX; Kim C; Nelson PT; Springer W; Kim J Mol Neurodegener; 2016 Jul; 11(1):55. PubMed ID: 27456084 [TBL] [Abstract][Full Text] [Related]
5. MiR-27a-3p/miR-27b-3p Promotes Neurofibromatosis Type 1 via Targeting of NF1. Lu H; Liu P; Pang Q J Mol Neurosci; 2021 Nov; 71(11):2353-2363. PubMed ID: 33570696 [TBL] [Abstract][Full Text] [Related]
6. SRRM2, a potential blood biomarker revealing high alternative splicing in Parkinson's disease. Shehadeh LA; Yu K; Wang L; Guevara A; Singer C; Vance J; Papapetropoulos S PLoS One; 2010 Feb; 5(2):e9104. PubMed ID: 20161708 [TBL] [Abstract][Full Text] [Related]
7. Expression Profiling of Blood microRNAs 885, 361, and 17 in the Patients with the Parkinson's disease: Integrating Interaction Data to Uncover the Possible Triggering Age-Related Mechanisms. Behbahanipour M; Peymani M; Salari M; Hashemi MS; Nasr-Esfahani MH; Ghaedi K Sci Rep; 2019 Sep; 9(1):13759. PubMed ID: 31551498 [TBL] [Abstract][Full Text] [Related]
8. Identification of plasma microRNA expression changes in multiple system atrophy and Parkinson's disease. Uwatoko H; Hama Y; Iwata IT; Shirai S; Matsushima M; Yabe I; Utsumi J; Sasaki H Mol Brain; 2019 May; 12(1):49. PubMed ID: 31088501 [TBL] [Abstract][Full Text] [Related]
9. Several miRNAs derived from serum extracellular vesicles are potential biomarkers for early diagnosis and progression of Parkinson's disease. He S; Huang L; Shao C; Nie T; Xia L; Cui B; Lu F; Zhu L; Chen B; Yang Q Transl Neurodegener; 2021 Jul; 10(1):25. PubMed ID: 34315539 [TBL] [Abstract][Full Text] [Related]
10. Role and Dysregulation of miRNA in Patients with Parkinson's Disease. Salemi M; Marchese G; Lanza G; Cosentino FII; Salluzzo MG; Schillaci FA; Ventola GM; Cordella A; Ravo M; Ferri R Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36614153 [TBL] [Abstract][Full Text] [Related]
11. Circulating miR-148b-3p and miR-27a-3p can be potential biomarkers for diagnosis of pre-diabetes and type 2 diabetes: integrating experimental and in-silico approaches. Ghoreishi E; Shahrokhi SZ; Kazerouni F; Rahimipour A BMC Endocr Disord; 2022 Aug; 22(1):207. PubMed ID: 35978298 [TBL] [Abstract][Full Text] [Related]
12. Identification of aberrant circulating miRNAs in Parkinson's disease plasma samples. Chen L; Yang J; Lü J; Cao S; Zhao Q; Yu Z Brain Behav; 2018 Apr; 8(4):e00941. PubMed ID: 29670823 [TBL] [Abstract][Full Text] [Related]
13. The transcardiac gradient of cardio-microRNAs in the failing heart. Marques FZ; Vizi D; Khammy O; Mariani JA; Kaye DM Eur J Heart Fail; 2016 Aug; 18(8):1000-8. PubMed ID: 27072074 [TBL] [Abstract][Full Text] [Related]
14. Combined serum CA19-9 and miR-27a-3p in peripheral blood mononuclear cells to diagnose pancreatic cancer. Wang WS; Liu LX; Li GP; Chen Y; Li CY; Jin DY; Wang XL Cancer Prev Res (Phila); 2013 Apr; 6(4):331-8. PubMed ID: 23430754 [TBL] [Abstract][Full Text] [Related]
15. miRNA-27a-3p and miRNA-222-3p as Novel Modulators of Phosphodiesterase 3a (PDE3A) in Cerebral Microvascular Endothelial Cells. Yasmeen S; Kaur S; Mirza AH; Brodin B; Pociot F; Kruuse C Mol Neurobiol; 2019 Aug; 56(8):5304-5314. PubMed ID: 30603956 [TBL] [Abstract][Full Text] [Related]
16. Elevated plasma miR-133b and miR-221-3p as biomarkers for early Parkinson's disease. Chen Q; Deng N; Lu K; Liao Q; Long X; Gou D; Bi F; Zhou J Sci Rep; 2021 Jul; 11(1):15268. PubMed ID: 34315950 [TBL] [Abstract][Full Text] [Related]
17. Downregulation of microRNA-27b-3p via aberrant DNA methylation contributes to malignant behavior of gastric cancer cells by targeting GSPT1. Zhang C; Zou Y; Dai DQ Biomed Pharmacother; 2019 Nov; 119():109417. PubMed ID: 31539861 [TBL] [Abstract][Full Text] [Related]
18. Aberrant expression of microRNAs in peripheral blood mononuclear cells as candidate biomarkers in patients with axial spondyloarthritis. Li X; Lv Q; Tu L; Zhao M; Zhang P; Li Q; Wei Q; Cao S; Gu J Int J Rheum Dis; 2019 Jul; 22(7):1188-1195. PubMed ID: 30990253 [TBL] [Abstract][Full Text] [Related]
19. miRNA-146a-5p is upregulated in serum and cartilage samples of patients with osteoarthritis. Skrzypa M; Szala D; Gablo N; Czech J; Pajak J; Kopanska M; Trzeciak M; Gargasz K; Snela S; Zawlik I Pol Przegl Chir; 2019 Feb; 91(3):1-5. PubMed ID: 31243168 [TBL] [Abstract][Full Text] [Related]
20. Association of the peripheral blood levels of circulating microRNAs with both recurrent miscarriage and the outcomes of embryo transfer in an in vitro fertilization process. Yang Q; Gu WW; Gu Y; Yan NN; Mao YY; Zhen XX; Wang JM; Yang J; Shi HJ; Zhang X; Wang J J Transl Med; 2018 Jul; 16(1):186. PubMed ID: 29973278 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]